Company intelligence
HEMARINA
Committed to saving lives.
Research Services
17 employees
Founded 2007
6 public signals
About HEMARINA
Hemarina is an innovative biotechnology company specializing in health product development based in Morlaix (29600, FR). Our search for new solutions based on the properties of the haemoglobin of the arenicola marina worm is permanent to improve the quality of life of patients and their families. Our commitment: to save lives by putting the patient at the heart of all our actions.
Verified activity
Signals from HEMARINA
6 published signals
Presence & Recognition
HEMARINA employee Franck Zal will participate in the Synchrotron SOLEIL conference on Monday, October 26, 2026, at 14h to present the study of the marine species Arenicola marina and its implications for new therapeutic solutions based on oxygen transport.
Reported by Franck Zal
Presence & Recognition
HEMARINA received the European Inventor Award for the scientific story of a marine worm, oxygen, and blood shortages.
Reported by Franck Zal
Presence & Recognition
HEMARINA won the European Inventor Award for Organ Transplantation
Reported by Franck Zal
Research & Knowledge
HEMARINA published a scientific paper discussing its first clinical observations in severe burns, including a patient with burns covering 85% of total body surface area.
Reported by Franck Zal
Legal & Regulatory
HEMARINA announced that ANSM recongnize the legal status of HEMHealing until this summer.
Reported by Franck Zal
Presence & Recognition
HEMARINA is participating in the FEB at Saint-Malo on September 10, 2026, at 11:00 in the Lamennais 3 room, to discuss the industrial sovereignty of France at the level of its SMEs.
Reported by Franck Zal